Iovance Biotherapeutics, Inc.
IOVA
$2.45
-$0.08-3.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 301.18M | 359.71M | 323.78M | 397.49M | 412.54M |
| Total Receivables | 59.94M | 70.94M | 69.34M | 55.77M | 31.60M |
| Inventory | 49.83M | 65.55M | 51.52M | 38.58M | 27.85M |
| Prepaid Expenses | 11.55M | 15.89M | 12.38M | 6.74M | 10.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 559.00K | -- | -- | 74.00K |
| Total Current Assets | 422.50M | 512.65M | 457.02M | 498.58M | 482.26M |
|
|
|||||
| Total Current Assets | 422.50M | 512.65M | 457.02M | 498.58M | 482.26M |
| Net Property, Plant & Equipment | 172.42M | 162.49M | 164.28M | 179.26M | 180.08M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 296.25M | 285.36M | 282.40M | 306.64M | 295.30M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.26M | 6.25M | 6.73M | 6.64M | 6.68M |
| Total Assets | 907.44M | 966.74M | 910.43M | 991.12M | 964.32M |
|
|
|||||
| Total Accounts Payable | 32.00M | 28.49M | 27.51M | 31.69M | 20.42M |
| Total Accrued Expenses | 78.05M | 77.49M | 75.19M | 72.76M | 60.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.07M | 9.50M | 12.90M | 11.55M | 11.44M |
| Total Finance Division Other Current Liabilities | 11.03M | 7.22M | 6.75M | 2.06M | 1.69M |
| Total Other Current Liabilities | 11.03M | 7.22M | 6.75M | 2.06M | 1.69M |
| Total Current Liabilities | 129.16M | 122.69M | 122.34M | 118.06M | 93.64M |
|
|
|||||
| Total Current Liabilities | 129.16M | 122.69M | 122.34M | 118.06M | 93.64M |
| Long-Term Debt | -- | -- | 1.00M | 1.00M | 1.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 45.10M | 44.22M | 44.37M | 66.39M | 69.25M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 34.70M | 31.96M | 32.32M | 32.22M | 31.90M |
| Total Liabilities | 208.95M | 198.88M | 200.02M | 217.66M | 195.78M |
|
|
|||||
| Common Stock & APIC | 3.29B | 3.26B | 3.10B | 3.06B | 2.99B |
| Retained Earnings | -2.61B | -2.50B | -2.38B | -2.31B | -2.22B |
| Treasury Stock & Other | 20.86M | 6.29M | -1.05M | 16.24M | 526.00K |
| Total Common Equity | 698.49M | 767.86M | 710.40M | 773.45M | 768.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.00K | 2.00K | 3.00K | 3.00K | 3.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.00K | 2.00K | 3.00K | 3.00K | 3.00K |
|
|
|||||
| Total Common Equity | 698.49M | 767.86M | 710.40M | 773.45M | 768.54M |
| Total Preferred Equity | 2.00K | 2.00K | 3.00K | 3.00K | 3.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 698.49M | 767.87M | 710.41M | 773.46M | 768.54M |
|
|
|||||